Investeringsoversigt

7775 investments

Titel Sort descending	Periode	Program
Development of a novel point-of-care device to measure inflammation (suPAR) in fingerprick blood	2021 - 2023	Innobooster
Development of a novel point-of-care device to measure inflammation (suPAR) in fingerprick blood Period 2021 - 2023 Region Region Hovedstaden Program Innobooster Area Ikke defineret Investment Percentage 33 Invested 2.8 mill. Budget 8.6 mill. Partners ViroGates A/S People VIROGATES A/S Read more about the project
Development of a peptide-based CD133-targeting optical probe for image-guided cancer surgery	2020 - 2023	Industrial Researcher
Development of a peptide-based CD133-targeting optical probe for image-guided cancer surgery Period 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.2 mill. Budget 1.2 mill. Partners University of Copenhagen, FluoGuide A/S People FluoGuide A/S Read more about the project
Development of a platform for isolation of circulating tumor cells to improve early cancer detection and diagnosis.	2017 - 2020	Industrial Researcher
Development of a platform for isolation of circulating tumor cells to improve early cancer detection and diagnosis. Period 2017 - 2020 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 22.79 Invested 1.1 mill. Budget 4.7 mill. Partners University of Copenhagen, VarCT Diagnostics ApS People VarCT Diagnostics ApS Read more about the project
Development of a Prophylactic Vaccine Against Hepatitis C Virus	2019 - 2020	Innoexplorer
Development of a Prophylactic Vaccine Against Hepatitis C Virus Period 2019 - 2020 Region Region Hovedstaden Program Innoexplorer Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.5 mill. Budget 1.5 mill. Partners HVIDOVRE HOSPITAL People HVIDOVRE HOSPITAL Read more about the project
Development of a Prophylactic Vaccine against Hepatitis C Virus	2023 - 2024	Innoexplorer
Development of a Prophylactic Vaccine against Hepatitis C Virus Period 2023 - 2024 Region Program Innoexplorer Area Ikke defineret Investment Percentage 100 Invested 1.5 mill. Budget 1.5 mill. Partners HVIDOVRE HOSPITAL People Read more about the project
Development of a Prophylactic Vaccine Against Hepatitis C Virus	2021 - 2022	Innoexplorer
Development of a Prophylactic Vaccine Against Hepatitis C Virus Period 2021 - 2022 Region Region Hovedstaden Program Innoexplorer Area Ikke defineret Investment Percentage 100 Invested 1.5 mill. Budget 1.5 mill. Partners HVIDOVRE HOSPITAL People HVIDOVRE HOSPITAL Read more about the project
Development of a Raman spectroscopy based control system for the U-Loop fermentor	2016 - 2019	Industrial Researcher
Development of a Raman spectroscopy based control system for the U-Loop fermentor Period 2016 - 2019 Region Region Sjælland Program Erhvervsforsker Area Produktion, Materialer, Digitalisering og IKT Investment Percentage 40.67 Invested 1.1 mill. Budget 2.6 mill. Partners Technical University of Denmark, UNIBIO A/S People UNIBIO A/S Read more about the project
Development of a screening kit for quality control of enzyme production	2016 - 2016	Innobooster
Development of a screening kit for quality control of enzyme production Period 2016 - 2016 Region Region Hovedstaden Program Innobooster Area Ikke defineret Investment Percentage 33.24 Invested 495.950 Budget 1.5 mill. Partners GLYCOSPOT IVS People GlycoSpot ApS Read more about the project
Development of a Single Cell RNA Sequencing platform for Bacteria to Delineate Antibiotic Hetero-resistance	2023 - 2026	Industrial Researcher
Development of a Single Cell RNA Sequencing platform for Bacteria to Delineate Antibiotic Hetero-resistance Period 2023 - 2026 Region Program Erhvervsforsker Area Ikke defineret Investment Percentage 60.7 Invested 1.1 mill. Budget 1.8 mill. Stafylokok-infektioner bliver ofte fejldiagnosticeret. Dette kan skyldes hetero-resistens hvor en bakteriepopulation udtrykker forskellige niveauer af resistens. I dag bliver subpopulationer af resistente bakterier sjældent opdaget under diagnostikken, hvilket kan resultere i fatal fejlbehandling. Derfor vil vi udforske denne niche kommercielt ved at udvikle en molekylær enkelt celle sekventeringsplatform til bakterielt RNA og hermed muliggøre udvikling af nøjagtige diagnostiske tests. Partners University of Copenhagen, AMPLEXA GENETICS A/S People Read more about the project
Development of a single photon source at telecom wavelength	2024 - 2027	Industrial Researcher
Development of a single photon source at telecom wavelength Period 2024 - 2027 Region Program Erhvervsforsker Area Ikke defineret Investment Percentage 44.15 Invested 1.1 mill. Budget 2.4 mill. Sparrow Quantum (SQ) er en førende udbyder af enkelt-foton-kilder ved 950 nm. Virksomheden har leveret til forskningsgrupper og kvantecomputerudviklere, og vil nu udvide sin produktportefølje for at kunne imødekomme kvantekommunikationsindustrien. For at træde ind på dette marked er en effektiv deterministisk kilde til højkvalitets enkeltfotoner ved 1310 nm (O-båndet), afgørende. Projektet sigter mod at udvikle en sådan kilde og derved spille en afgørende rolle i kvantekommunikationsmarkedet. Partners University of Copenhagen, Sparrow Quantum ApS People Read more about the project
Development of a Sustainable Emulsification Device	2024 - 2026	Innobooster
Development of a Sustainable Emulsification Device Period 2024 - 2026 Region Program Innobooster Area Ikke defineret Investment Percentage 35 Invested 1.4 mill. Budget 4.1 mill. Partners Inmold A/s People Read more about the project
Development of a sustainable fermentation process for high value lipoic acid	2018 - 2020	Innobooster
Development of a sustainable fermentation process for high value lipoic acid Period 2018 - 2020 Region Region Hovedstaden Program Innobooster Area Biotek, Medico og Sundhed Investment Percentage 32.9 Invested 4.8 mill. Budget 14.7 mill. Partners Biosyntia ApS People BIOSYNTIA ApS Read more about the project
Development of a therapeutic HER2 based vaccine against breast cancer	2019 - 2022	Industrial Researcher
Development of a therapeutic HER2 based vaccine against breast cancer Period 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 45.3 Invested 1.2 mill. Budget 2.7 mill. Partners University of Copenhagen, AdaptVac ApS People AdaptVac ApS Read more about the project
Development of a therapeutic vaccine targeting HER2 positive breast cancer	2019 - 2020	Innobooster
Development of a therapeutic vaccine targeting HER2 positive breast cancer Period 2019 - 2020 Region Program Innobooster Area Biotek, Medico og Sundhed Investment Percentage 33 Invested 808.500 Budget 2.5 mill. Partners AdaptVac People Aktiv Read more about the project
Development of a translational mouse model of diabetic heart disease	2021 - 2025	Industrial Researcher
Development of a translational mouse model of diabetic heart disease Period 2021 - 2025 Region Region Hovedstaden Program Erhvervsforsker Area Ikke defineret Investment Percentage 53.73 Invested 1.1 mill. Budget 2.0 mill. Partners University of Copenhagen, GUBRA ApS People GUBRA ApS Read more about the project